 |
|
High Attributable Risk of Elevated C-Reactive Protein Level to Conventional Coronary Heart Disease Risk Factors
The Third National Health and Nutrition Examination Survey
Michael Miller, MD;
Min Zhan, PhD;
Stephen Havas, MD, MPH, MS
Arch Intern Med. 2005;165:2063-2068.
Background C-reactive protein (CRP), a marker of systemic inflammation, is predictive of coronary heart disease (CHD) events. However, the extent to which high CRP levels (>3 mg/L) may be attributable to high cholesterol levels and other CHD risk factors has not been well defined.
Methods The prevalence of high CRP levels in the third National Health and Nutrition Examination Survey (n = 15 341) was studied using CHD risk-factor cut points designated as abnormal (total cholesterol values,  240 mg/dL [6.22 mmol/L]; fasting blood glucose levels, 126 mg/dL [6.99 mmol/L]; blood pressure, 140/90 mm Hg; body mass index [BMI], 30 kg/m2; high-density lipoprotein cholesterol values, <40 mg/dL [<1.04 mmol/L] for men and <50 mg/dL [<1.30 mmol/L] for women; triglyceride levels, 200 mg/dL [2.26 mmol/L]; current smoking status) or borderline (total cholesterol values, 200-239 mg/dL [5.18-6.19 mmol/L]; fasting blood glucose levels, 100-125 mg/dL [5.55-6.94 mmol/L]; blood pressure, 120-139/80-89 mm Hg; BMI, 25.0-29.9 kg/m2, and triglyceride values 150-199 mg/dL [1.70-2.25 mmol/L], former smoking status), or normal.
Results Weighted multiple logistic regression analysis demonstrated that high CRP level was significantly more common with obesity (odds ratio [OR], 3.78; 95% confidence interval [CI], 3.28-4.35]), overweight (OR, 1.88; 95% CI, 1.62-2.18), and diabetes (OR, 1.91; 95% CI, 1.54-2.38) and that high CRP level was rare in the absence of any borderline or abnormal CHD risk factor in men (4.4%) and women (10.3%). Overall, the risk of elevated CRP level attributable to the presence of any abnormal or borderline CHD risk factor was 78% in men and 67% women.
Conclusions These data suggest that elevated CRP levels in the general population are in large measure attributable to traditional CHD risk factors. Moreover, CRP level elevation is rare in the absence of borderline or abnormal risk factors. As such, CRP measurements may have limited clinical utility as a screening tool beyond other known CHD risk factors.
Author Affiliations: Departments of Medicine (Drs Miller and Havas) and Epidemiology and Preventive Medicine (Drs Miller, Zhan, and Havas), University of Maryland School of Medicine, Baltimore.
RELATED LETTERS
The Role of Inflammation for Heart Disease Risk Cannot Be Determined by Correlations Between C-Reactive Protein and Risk Factors
Gunnar Engström
Arch Intern Med. 2006;166(9):1040.
EXTRACT
| FULL TEXT
The Role of Inflammation for Heart Disease Risk Cannot Be Determined by Correlations Between C-Reactive Protein and Risk Factors—Reply
Michael Miller and Stephen Havas
Arch Intern Med. 2006;166(9):1040-1041.
EXTRACT
| FULL TEXT
RELATED ARTICLES
The Role of Inflammation for Heart Disease Risk Cannot Be Determined by Correlations Between C-Reactive Protein and Risk Factors—Reply
Michael Miller and Stephen Havas
Arch Intern Med. 2006;166(9):1040-1041.
EXTRACT
| FULL TEXT
C-Reactive Protein, Heart Disease Risk, and the Popular Media
Russell P. Tracy and Lewis H. Kuller
Arch Intern Med. 2005;165(18):2058-2060.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans
Anuurad et al.
J. Clin. Endocrinol. Metab. 2008;93:1482-1488.
ABSTRACT
| FULL TEXT
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality
Currie et al.
Heart 2008;94:457-462.
ABSTRACT
| FULL TEXT
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi and Cooper
Endocr. Rev. 2008;29:76-131.
ABSTRACT
| FULL TEXT
Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future
Revkin et al.
Pharmacol. Rev. 2007;59:40-53.
ABSTRACT
| FULL TEXT
C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Sattar et al.
Circulation 2007;115:981-989.
ABSTRACT
| FULL TEXT
C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge
Capuzzi and Freeman
Clin. Diabetes 2007;25:16-22.
ABSTRACT
| FULL TEXT
Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey
Crawford et al.
Circulation 2006;114:2458-2465.
ABSTRACT
| FULL TEXT
Risk Stratification in Secondary Prevention: Advances in Multimarker Profiles, or Back to Basics?
Kistorp
Circulation 2006;114:184-186.
FULL TEXT
Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Blankenberg et al.
Circulation 2006;114:201-208.
ABSTRACT
| FULL TEXT
Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
Lloyd-Jones et al.
ANN INTERN MED 2006;145:35-42.
ABSTRACT
| FULL TEXT
The role of inflammation for heart disease risk cannot be determined by correlations between C-reactive protein and risk factors.
Engstrom
Arch Intern Med 2006;166:1040-1040.
FULL TEXT
The Role of Inflammation for Heart Disease Risk Cannot Be Determined by Correlations Between C-Reactive Protein and Risk Factors--Reply
Miller and Havas
Arch Intern Med 2006;166:1040-1041.
FULL TEXT
C-Reactive Protein and Insulin Resistance: An Independent Risk Factor for CVD?
Heubeck
DOC News 2006;3:10-11.
FULL TEXT
Do Traditional CHD Risk Factors Explain CRP Elevations?
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT
C-Reactive Protein and Traditional Coronary Risk Factors
JWatch General 2005;2005:1-1.
FULL TEXT
C-Reactive Protein, Heart Disease Risk, and the Popular Media
Tracy and Kuller
Arch Intern Med 2005;165:2058-2060.
FULL TEXT
|
